查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190566

皮膚科設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Dermatology Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

皮膚科設備市場預計在預測期內（2022 年至 2027 年）將以 12.3% 的複合年增長率增長。

COVID-19 大流行的爆發對皮膚病設備市場產生了重大影響。 非必要業務的關閉擾亂了皮膚科行業。 Hamilton Fraser Cosmetic Insurance 於 2020 年 3 月對 1,360 名英國美容從業者進行調查，以評估大流行對其美容實踐的影響，發現 99.78% 的從業者受到大流行的影響。據稱，他透露自己受到了手術的影響當時。 因此，雖然 COVID-19 在大流行期間對市場增長率產生了重大影響，但由於全球封鎖升級和美容治療的恢復，預計市場將隨著時間的推移而增長。

老年人口的增加、美容醫學意識的增強以及皮膚醫療設備的技術進步等因素預計將推動市場增長。

世界各地越來越多的整容手術也產生了對皮膚科設備的需求，從而促進了市場的增長。 例如，根據國際整形與重建外科學會2021年12月發布的報告，2020年全球進行的整容/整容手術總數為1,624,281例，抽脂術（1,525,197例）、雙眼皮手術（1,225,540例）、隆鼻術(852,554) 和腹部整形術 (765,248)。 此外，技術先進產品的推出也推動了市場增長。 例如，2021年12月，科學護膚公司、專業護膚產品領導者之一的Obagi推出了Skintrinsiq設備，標誌著其進軍輔助護膚設備市場。 Obagi 是最早設計和開發專業面部設備的專業護膚公司之一，為 Obagi 的創新產品提供先進的輸送系統。

此外，市場參與者的戰略舉措和產品批准也在推動市場增長。 例如，2022 年 6 月，卡西歐計算機完成了歐洲醫療器械法規 (MDR) 合規性研究，並為其 DZ-D100 皮膚病相機和 DZ-S50 皮膚病鏡發布了歐盟合規性聲明。 此外，“DZ-D100”和“DZ-S50”計劃於2022年8月在歐洲發售，由卡西歐歐洲（德國諾德施泰特）和卡西歐電子（英國溫布利）銷售。據悉預定。 預計這些努力將對市場增長產生積極影響。

通過這些努力，該市場有望在未來實現顯著增長。 然而，與皮膚病治療相關的副作用和有關醫療器械的嚴格監管政策可能會阻礙分析期間的市場增長。

主要市場趨勢

預計抗皺領域在預測期內將呈現高增長

由於老年人和老年人口的負擔不斷增加，以及隨著產品的推出和批准，人們對整容手術的認識不斷提高，預計抗皺領域在預測期內將出現顯著增長。

人口老齡化也在推動這一細分市場的增長。 例如，根據加拿大統計局的 2021 年人口普查，2021 年加拿大 65 歲及以上人口大約有 7,021,430 人，其中男性 3,224,680 人，女性 3,796,750 人。 老齡化和老年人口的增加最終將導致面部老化並引起皺紋，這將增加對這些設備的需求。

此外，國家推出基於先進技術的除皺設備也有助於該細分市場的增長。 例如，2022 年 1 月，Lumenis 在英國市場推出了 Splendor X 設備。 該設備已通過 CE 認證，可用於治療脫髮、血管治療、色素病變和皺紋。 該儀器配備了 BLEND X 技術，可發射波長同步的 Nd:YAG（1064 nm）和紫翠玉（755 nm）比例可控的二元激光。 預計此類發布將推動該細分市場的增長。 此外，2021 年 4 月，Crown Laboratories 的一個部門 Crown Esthetics 獲得了美國食品和藥物管理局 (FDA) 的 SkinPen Precision 治療頸部皺紋的許可。 預計此類批准也將促進市場的增長。

由於上述原因，市場有望在預測期內增長。

北美在皮膚科設備市場佔有最大份額

北美佔所研究市場的主要份額。 再加上皮膚癌、濕疹和紅斑痤瘡等皮膚病患病率上升，皮膚科設備獲得批准，以及人們對整容手術的認識不斷提高，這種趨勢可能會持續下去。

根據美國癌症協會 2022 年的統計數據，美國預計將在 2022 年報告 99,780 例皮膚黑色素瘤新病例。 其中，登記了 57,180 例男性病例和 42,600 例女性病例。 因此，皮膚癌和其他皮膚病負擔的增加極大地促進了對皮膚病設備的需求增加，從而促進了市場的增長。

此外，一些醫療技術公司正在專注於使患者護理更便宜、更快捷、更高效的產品。 例如，2020 年 7 月，Lancer Skin Care 推出了 Pro Polish 微晶換膚儀。 Propolish 通過在獲得專利的手持設備中提供淺表微晶換膚術，提高了 Lancer 常規的有效性。 皮膚科設備的這種功能進步及其在皮膚病中的廣泛應用預計將加強該地區對皮膚科設備的需求。 此外，2020 年 6 月，AbbVie（Allergan Esthetics）獲得美國食品和藥物管理局批准，將 JUVEDERM VOLUMA XC 作為一種頜骨增強手術，用於改善 21 歲及以上成年人的頜骨輪廓。知道了。 此類批准也在推動市場增長。

因此，由於上述因素，預計北美市場在預測期內將出現可觀的增長。

競爭格局

皮膚科設備市場的競爭很低。 市場參與者正在通過不斷創新市場上已有的設備來改進現有產品組合，從而擴展他們的皮膚病設備組合。 它還採取了增長戰略，例如擴大產品線、地域擴張和擴大客戶群。 主要參與者包括 Cutera Inc.、Hologic Inc.（Cynosure Inc.）、Lumenis Ltd.、Alma Lasers 和 Candela Corporation。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 皮膚病發病率增加
    • 皮膚護理設備的技術進步
    • 對整容手術的認識不斷提高
  • 市場製約因素
    • 與皮膚病治療相關的副作用
    • 嚴格的醫療器械監管政策
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按診斷設備類型
    • 成像設備
    • 皮膚鏡
    • 顯微鏡
  • 通過使用診斷設備
    • 皮膚癌的診斷
    • 其他診斷設備應用
  • 按治療設備類型
    • 光療設備
    • 激光
    • 電外科單元
    • 吸脂器
    • 微晶換膚術
    • 冷凍治療設備
  • 通過使用治療設備
    • 血管病變
    • 痤瘡、牛皮癬、去除紋身
    • 脫毛
    • 除皺
    • 塑身和去除脂肪
    • 其他治療設備應用
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Abbvie Inc.（Allergan Inc.）
    • Alma Lasers Ltd
    • Bausch Health Companies Inc.（Solta Medical Inc.）
    • BrUnited Kingdomer Corporation
    • CANDELA CORPORATION
    • Carl Zeiss
    • Cutera Inc.
    • Galderma SA
    • Genesis Biosystems Inc.
    • Hologic Inc.（Cynosure Inc.）
    • Lumenis Ltd
    • Merz Pharma GmbH & Co. KGaA

第7章 市場機會今後動向

簡介目錄
Product Code: 64170

The Dermatology Devices Market is expected to register a CAGR of 12.3% during the forecast period (2022-2027).

The outbreak of the COVID-19 pandemic significantly impacted the dermatology devices market. The closure of non-essential businesses disrupted the dermatology industry. According to a survey by Hamilton Fraser Cosmetic Insurance, conducted in March 2020 with 1,360 cosmetic practitioners in United Kingdom to assess the impact of the pandemic on cosmetic procedures, stated that 99.78% of practitioners revealed that their practice was affected during the current pandemic. Thus, COVID-19 significantly impacted the growth rate of the market over the pandemic phase, although, with the upliftment of the lockdowns and the resumption of cosmetic treatments globally, the market is expected to show growth over time.

Factors such as the growing geriatric population, increasing awareness about aesthetic procedures, and technological advancements in dermatology devices are expected to propel the growth of the market.

The growing number of aesthetic procedures performed across the world also creates the need for dermatological devices and hence drives the growth of the market. For instance, according to the International Society of Plastic Surgeons report released in December 2021, the total number of aesthetic/cosmetic procedures performed in the year 2020 worldwide for breast augmentation were 1,624,281, liposuction (1,525,197), eyelid surgery (1,225,540), rhinoplasty (852,554), and abdominoplasty (765,248). Furthermore, the launch of technologically advanced products is also propelling the growth of the market. For instance, in December 2021, Obagi, a science-based skincare company and one of the leaders in professional skincare products, launched the Skintrinsiq device and made its entry into the complementary skincare device market. Obagi is one of the first professional skincare companies to design and develop a professional-use facial device offering an advanced delivery system for Obagi's transformational products.

Additionally, the strategic initiatives taken by the market players and approvals for the products are also boosting the growth of the market. For instance, in June 2022, Casio Computer Co., Ltd. issued an EU Declaration of Conformity regarding the DZ-D100 dermatology camera and DZ-S50 dermatology scope after the completion of conformity studies for European Medical Device Regulations (MDR). It also reported that the DZ-D100 and DZ-S50 are expected to launch in Europe in August 2022 and are scheduled to be sold by Casio Europe GmbH (Norderstedt, Germany) and Casio Electronics Co. Ltd. (Wembley, United Kingdom). Such initiatives are expected to have a positive impact on the growth of the market.

Thus, owing to the abovementioned factors, the market is expected to have significant growth over the forecast period. However, the side effects related to dermatological treatments and stringent regulatory policies for medical devices may hamper the growth of the market over the analysis period.

Key Market Trends

Wrinkle Removal Segment is Anticipated to Show High Growth Over the Forecast Period

The wrinkle removal segment is expected to project significant growth over the forecast period owing to factors such as the growing burden of the elderly and geriatric population, and increasing awareness about aesthetic procedures coupled with the launch and approval of the products.

The growing geriatric population is also boosting the growth of the market segment. For instance, as per the Statistics Canada 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females, living in Canada in 2021. Such a rise in the geriatric and elderly population ultimately results in facial aging, leading to wrinkles, thereby boosting the demand for these devices.

Additionally, the launch of wrinkle removal devices based on advanced technology in the country is also contributing to the growth of the segment. For instance, in January 2022, Lumenis launched the Splendor X device into United Kingdom market. The device has already received a CE mark for hair removal, vascular treatments, pigmented lesions, and the treatment of wrinkles. The system is powered by BLEND X technology, which emits a binary laser at synchronized and controllable ratios of Nd: YAG (1064 nm) and Alexandrite (755 nm) wavelengths. Such launches are expected to propel the growth of the market segment. Furthermore, in April 2021, Crown Aesthetics, a division of Crown Laboratories, Inc., received United States Food and Drug Administration (FDA) clearance for SkinPen Precision for the treatment of wrinkles on the neck. Such approvals are also expected to boost the growth of the market segment.

Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.

North American Region Holds the Largest Market Share of Dermatology Devices Market

North America accounted for the major share of the market studied. This trend is likely to continue due to the increasing prevalence of skin cancer and other skin diseases, such as eczema and rosacea, coupled with approval for dermatological devices and increasing awareness about aesthetic procedures.

According to the American Cancer Society's 2022 statistics, in United States, an estimated 99,780 new cases of melanoma of the skin are expected to be reported in 2022. Of those, 57,180 cases are likely to be registered among males and 42,600 in females. Thus, the rising burden of skin cancer and other skin diseases is a major contributor to the increasing demand for dermatology devices, thus boosting the growth of the market.

Moreover, several medical technology companies focus on products that deliver less expensive, quicker, and more efficient patient care. For instance, in July 2020, Lancer Skincare launched the Pro Polish Microdermabrasion Device. Pro Polish enhances the efficacy of the Lancer routine by delivering surface-layer microdermabrasion in a patented, handheld device. These advancements in dermatology devices, in terms of features and wide-scale application for skin diseases, are expected to bolster the demand for dermatology devices in the region. Additionally, in June 2020, AbbVie Inc. (Allergan Aesthetics) received United States Food and Drug Administration approval for JUVEDERM VOLUMA XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. Such approvals are also boosting the growth of the market.

Thus, owing to the abovementioned factors, the studied market is expected to project considerable growth over the forecast period in North America.

Competitive Landscape

The dermatology devices market is moderately competitive. The market players are expanding the dermatology devices portfolio by improving their existing product portfolios with continuous innovation in the devices that are already available in the market. The players are also adopting growth strategies to expand their product offerings, strengthen their geographical reach, and increase their customer base. Some of the major players include Cutera Inc., Hologic Inc. (Cynosure Inc.), Lumenis Ltd., Alma Lasers, Candela Corporation, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidences of Skin Disorders
    • 4.2.2 Technological Advancements in Skin Care Devices
    • 4.2.3 Increasing Awareness on Aesthetic Procedures
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Related To Dermatological Treatments
    • 4.3.2 Stringent Regulatory Policies for Medical Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Diagnostic Devices Type
    • 5.1.1 Imaging Devices
    • 5.1.2 Dermatoscopes
    • 5.1.3 Microscopes
  • 5.2 By Diagnostic Devices Application
    • 5.2.1 Skin Cancer Diagnosis
    • 5.2.2 Other Diagnostic Device Applications
  • 5.3 By Treatment Devices Type
    • 5.3.1 Light Therapy Devices
    • 5.3.2 Lasers
    • 5.3.3 Electrosurgical Equipment
    • 5.3.4 Liposuction Devices
    • 5.3.5 Microdermabrasion Devices
    • 5.3.6 Cryotherapy Devices
  • 5.4 By Treatment Devices Application
    • 5.4.1 Vascular Lesions
    • 5.4.2 Acne, Psoriasis, and Tattoo Removal
    • 5.4.3 Hair Removal
    • 5.4.4 Wrinkle Removal
    • 5.4.5 Body Contouring and Fat Removal
    • 5.4.6 Other Treatment Device Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbvie Inc. (Allergan Inc.)
    • 6.1.2 Alma Lasers Ltd
    • 6.1.3 Bausch Health Companies Inc. (Solta Medical Inc.)
    • 6.1.4 Bruker Corporation
    • 6.1.5 CANDELA CORPORATION
    • 6.1.6 Carl Zeiss
    • 6.1.7 Cutera Inc.
    • 6.1.8 Galderma SA
    • 6.1.9 Genesis Biosystems Inc.
    • 6.1.10 Hologic Inc. (Cynosure Inc.)
    • 6.1.11 Lumenis Ltd
    • 6.1.12 Merz Pharma GmbH & Co. KGaA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS